Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices (Chicago, IL - July 26-27, 2018) - ResearchAndMarkets.com

Published: Apr 13, 2018

Federal regulation of the advertising and promotion of pharmaceuticals and medical devices reflects an aggressive attitude on the part of the regulators that demands, in turn, that industry be keenly aware of the legal and regulatory duties, as well as key recent trends in enforcement activities by the Federal Government. This course will explore in detail what FDA requires of drug and device firms as well as recent current hot buttons in FDA enforcement activity for the advertising arena.

What's at stake if your advertising and promotional efforts violate the law? Colossal fines - the latest was $3 Billion; criminal liability, including even prison time; and huge disruption in operations while dealing with federal probes into illegal marketing.

Who will Benefit:

Senior executives, directors, managers and those who have responsibility for implementing advertising and promotional activities, as well as those that have key collateral roles in reviewing advertising for drug and device firms, including officials from these areas within regulated companies:

  • Sales
  • Marketing
  • Medical Affairs
  • Legal
  • Regulatory
  • Compliance

Agenda:

I. Understanding the Basics

II. Scientific Exchange

III. First Amendment

IV. Websites & Social Media

V. Enforcement Trends

VI. False Claims Act and Criminal Liability

VII. Handling at the Company Level

For more information about this conference visit https://www.researchandmarkets.com/research/gs3c6d/_ensuring?w=4

Back to news